RNA packaging into extracellular vesicles: An orchestra of RNA‐binding proteins?
Extracellular vesicles (EVs) are heterogeneous membranous particles released from the
cells through different biogenetic and secretory mechanisms. We now conceive EVs as …
cells through different biogenetic and secretory mechanisms. We now conceive EVs as …
Molecular aspects of cancer cell resistance to chemotherapy
M Rebucci, C Michiels - Biochemical pharmacology, 2013 - Elsevier
Cancer cell resistance to chemotherapy is still a heavy burden that impairs treatment of
cancer patients. Both intrinsic and acquired resistance results from the numerous genetic …
cancer patients. Both intrinsic and acquired resistance results from the numerous genetic …
Y-box-binding protein 1 (YB-1) and its functions
IA Eliseeva, ER Kim, SG Guryanov… - Biochemistry …, 2011 - Springer
This review describes the structure and functions of Y-box binding protein 1 (YB-1) and its
homologs. Interactions of YB-1 with DNA, mRNAs, and proteins are considered. Data on the …
homologs. Interactions of YB-1 with DNA, mRNAs, and proteins are considered. Data on the …
A comprehensive review of the functions of YB-1 in cancer stemness, metastasis and drug resistance
The Y Box binding protein 1 (YB-1) is a member of the highly conserved Cold Shock Domain
protein family with multifunctional properties both in the cytoplasm and inside the nucleus …
protein family with multifunctional properties both in the cytoplasm and inside the nucleus …
YB-1: oncoprotein, prognostic marker and therapeutic target?
Hanahan and Weinberg have proposed the 'hallmarks of cancer'to cover the biological
changes required for the development and persistence of tumours [Hanahan and Weinberg …
changes required for the development and persistence of tumours [Hanahan and Weinberg …
YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer
D Jiang, T Qiu, J Peng, S Li, Tala, W Ren… - Cell Death & …, 2022 - nature.com
Y-box binding protein 1 (YB-1) is a well-known oncogene highly expressed in various
cancers, including basal-like breast cancer (BLBC). Beyond its role as a transcription factor …
cancers, including basal-like breast cancer (BLBC). Beyond its role as a transcription factor …
Oncogenic Y‐box binding protein‐1 as an effective therapeutic target in drug‐resistant cancer
M Kuwano, T Shibata, K Watari, M Ono - Cancer science, 2019 - Wiley Online Library
Y‐box binding protein‐1 (YBX 1), a multifunctional oncoprotein containing an evolutionarily
conserved cold shock domain, dysregulates a wide range of genes involved in cell …
conserved cold shock domain, dysregulates a wide range of genes involved in cell …
Y-Box Binding Protein-1 Induces the Expression of CD44 and CD49f Leading to Enhanced Self-Renewal, Mammosphere Growth, and Drug Resistance
K To, A Fotovati, KM Reipas, JH Law, K Hu, J Wang… - Cancer research, 2010 - AACR
Abstract Y-box binding protein-1 (YB-1) is an oncogenic transcription/translation factor
expressed in> 40% of breast cancers, where it is associated with poor prognosis, disease …
expressed in> 40% of breast cancers, where it is associated with poor prognosis, disease …
Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness
M Costantini, P Belli, P Rinaldi, E Bufi, G Giardina… - Clinical radiology, 2010 - Elsevier
AIM: To assess the utility of diffusion-weighted imaging in diagnosing and characterizing
breast malignancy. MATERIALS AND METHODS: From April 2006 to April 2009, all …
breast malignancy. MATERIALS AND METHODS: From April 2006 to April 2009, all …
Breast cancers: MR imaging of folate-receptor expression with the folate-specific nanoparticle P1133
Purpose To assess the capability of the folate receptor (FR)-targeted ultrasmall
superparamagnetic iron oxide (USPIO) P1133 to provide FR-specific enhancement of breast …
superparamagnetic iron oxide (USPIO) P1133 to provide FR-specific enhancement of breast …